Literature DB >> 17044555

Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience.

Shigetoshi Yano1, Jun-ichi Kuratsu.   

Abstract

OBJECT: To determine the indications for surgery in patients harboring asymptomatic meningiomas, the authors retrospectively analyzed the natural course and surgical outcome of asymptomatic meningiomas and then compared these to the natural course and surgical outcome of symptomatic meningiomas.
METHODS: Between 1989 and 2003, 1434 patients harboring meningiomas, who were treated in Kumamoto Prefecture, Japan, were enrolled in this study. Six hundred three patients had asymptomatic lesions and 831 had symptomatic ones. The authors analyzed the sizes of the lesions at detection, their growth over time, and any appearances of symptoms associated with previously asymptomatic meningiomas. The authors then compared the surgery-related morbidity rates associated with asymptomatic and symptomatic meningiomas arising at different locations. Of the 603 asymptomatic meningiomas, 351 (58.2%) were treated conservatively. Tumor growth was observed in 25 (37.3%) of 67 patients who participated in follow up for longer than 5 years, and symptoms developed in 11 (16.4%) of the 67 patients over a mean follow-up period of 3.9 years. Among the 213 patients with surgically treated asymptomatic meningiomas, the morbidity rate was 4.4% in patients younger than 70 years of age and 9.4% in those 70 years of age or older. Although the total morbidity rate was lower in patients with asymptomatic lesions than in those with symptomatic ones, it exceeded 6% in patients whose asymptomatic tumors were located at the convexity or falx.
CONCLUSIONS: Approximately 63% of asymptomatic meningiomas did not exhibit tumor growth, and only 6% of all patients with these lesions experienced symptoms during the observation period. To avoid surgery-related incidences of morbidity in patients with asymptomatic meningiomas, conservative treatment with close follow-up review may be the best therapeutic strategy.

Entities:  

Mesh:

Year:  2006        PMID: 17044555     DOI: 10.3171/jns.2006.105.4.538

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  38 in total

1.  Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act.

Authors:  Therese A Dolecek; Emily Van Meter Dressler; Jigisha P Thakkar; Meng Liu; Abeer Al-Qaisi; John L Villano
Journal:  Cancer       Date:  2015-04-14       Impact factor: 6.860

2.  Incidental finding of tumor while investigating subarachnoid hemorrhage: ethical considerations and practical strategies.

Authors:  Doniel Drazin; Kevin Spitler; Milos Cekic; Ashish Patel; George Hanna; Ali Shirzadi; Ray Chu
Journal:  Sci Eng Ethics       Date:  2012-10-13       Impact factor: 3.525

3.  A new metric for detecting change in slowly evolving brain tumors: validation in meningioma patients.

Authors:  Kilian M Pohl; Ender Konukoglu; Sebastian Novellas; Nicholas Ayache; Andriy Fedorov; Ion-Florin Talos; Alexandra Golby; William M Wells; Ron Kikinis; Peter M Black
Journal:  Neurosurgery       Date:  2011-03       Impact factor: 4.654

4.  Treatment policy for petroclival meningioma based on tumor size: aiming radical removal in small tumors for obtaining cure without morbidity.

Authors:  Iwao Yamakami; Yoshinori Higuchi; Kentaro Horiguchi; Naokatsu Saeki
Journal:  Neurosurg Rev       Date:  2011-02-22       Impact factor: 3.042

5.  Growth curve analysis of asymptomatic and symptomatic meningiomas.

Authors:  Satoshi Nakasu; Yoko Nakasu; Tadateru Fukami; Junya Jito; Kazuhiko Nozaki
Journal:  J Neurooncol       Date:  2010-08-05       Impact factor: 4.130

Review 6.  [Clinical magnetic resonance imaging : Frequent incidental cerebral findings].

Authors:  A Müller; P Ditter; S Weidauer; H-H Schild; E Hattingen
Journal:  Radiologe       Date:  2017-04       Impact factor: 0.635

7.  A microcosting study of microsurgery, LINAC radiosurgery, and gamma knife radiosurgery in meningioma patients.

Authors:  Siok Swan Tan; Erik van Putten; Wideke M Nijdam; Patrick Hanssens; Guus N Beute; Peter J Nowak; Clemens M Dirven; Leona Hakkaart-van Roijen
Journal:  J Neurooncol       Date:  2010-06-06       Impact factor: 4.130

Review 8.  Management options for cavernous sinus meningiomas.

Authors:  Michael T Walsh; William T Couldwell
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

9.  Meningiomas.

Authors:  Sean Grimm; Jeffrey J Raizer
Journal:  Curr Treat Options Neurol       Date:  2008-07       Impact factor: 3.598

Review 10.  Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Zoe Morris; William N Whiteley; W T Longstreth; Frank Weber; Yi-Chung Lee; Yoshito Tsushima; Hannah Alphs; Susanne C Ladd; Charles Warlow; Joanna M Wardlaw; Rustam Al-Shahi Salman
Journal:  BMJ       Date:  2009-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.